lung infection pneumonia RTI lung infection
Conditions
Interventions
For this HOME-ART intervention, we aim to align the medical treatment as
closely as possible with regular hospital care. This means that patients who
are randomized in the intervention group will re
Sponsors
Universitair Medisch Centrum Utrecht
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a patient must meet the following criteria: - Mentally competent adult (>=18 years) - Clinical diagnosis of community acquired respiratory tract infection in which hospital admission is considered required - Availability of informal caregiver who is willing to provide support at home and agrees to participate in the study program and understands its implications after being informed by the research staff - A good command of the Dutch language
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Patients who lack adequate digital proficiency to properly conduct digital aspects of the study - Respiratory distress requiring more than 5 litres of oxygen therapy to achieve comfort and a saturation of >= 94% at discharge from ER and/or a patient with clinical signs of respiratory exhaustion - Absence of haemodynamic stability at discharge from the ER, in which patient required > 2 500cc fluid challenges during ER admission and/or maintenance i.v. fluid suppletion is required - Patients requiring follow-up diagnostics in clinical setting - Serious risk of decompensation of pre-existent chronic illness, such as COPD, heart failure, immune deficiency, kidney- or liver failure, warranting hospital observation as judged by the responsible physician. - Hospital admission 30 days prior to ED presentation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study endpoint will be the clinical effectiveness of the intervention, defined as the difference in mean number of days alive out of hospital (DOAH) within 30 days after randomization. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary study outcomes are feasibility of the intervention in a regional network, safety (in terms of ICU admissions, delirium, all-cause mortality, patient's experienced safety during the intervention, disability-free survival within 30 days after randomization), health resources use, patient autonomy, strain on informal carers, user satisfaction and cost-effectiveness of the intervention. | — |
Countries
Netherlands
Contacts
Public Contacta ahmad
Universitair Medisch Centrum Utrecht
Outcome results
None listed